Frank Albanese, who appeared in The Sopranos and Goodfellas, died on Monday, The New York Timesreports. He was 84. According to his friend Eddie Canlon, Albanese lost his battle with metastatic prostate cancer. Before pursuing an acting career, Albanese was a heavyweight prizefighter who trained under... Read More > Other Links From TVGuide.com The Sopranos
A compound discovered and developed by a team of Georgetown Lombardi Comprehensive Cancer Center researchers that halts cancer in animals with Ewing sarcoma and prostate cancer appears to work against some forms of leukemia, too. That finding and the team's latest work was published in Oncotarget.
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk. In contrast, obesity, alcohol abuse, and smoking show a negative association with the disease.
A chronic under investment in radiotherapy resources is leading to millions of preventable deaths from treatable cancers like breast and prostate cancer, according to a major new Commission on access to radiotherapy, published in The Lancet Oncology. New estimates produced for the Commission reveal that 204 million fractions of radiotherapy will be needed to treat the 12 […]
Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research. The results could mean men need fewer trips to hospital – over four weeks rather than seven and a half – without reducing the quality and impact of their prostate cancer treatment.
Treatment decisions are complicated for men with low-risk prostate cancer that grows slowly. These cancers may never become deadly during a man’s expected lifespan. And there is no conclusive evidence showing that treatment in these cases extends survival. Show More Summary
The US Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and overtreatment, the reduction in intermediate...Show More Summary
Many many are at greater risk for intermediate- and high-risk prostate cancers as a result of USPSTF recommendations against regular screening for the disease, a new study finds.
Research published recently in Science as Culture suggests that men are surprisingly positive and open to the concept of having cancer-detecting biosensors implanted within their bodies – effectively making them cyborgs. read more
Men are surprisingly positive and open to the concept of having cancer-detecting biosensors implanted within their bodies – effectively making them cyborgs -- new research suggests.
A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, researchers report. The American Cancer Society reports that prostate cancer is the second leading cause of cancer death in American men, behind lung cancer, with about 220,800 new cases estimated in 2015.
You've seen him on the N or the R, thin with jaundiced skin and cropped gray hair. He humbly apologizes for interrupting but he hasn't eaten for two day and has prostate cancer too. He offers his services, as a Mr. Fix-it, though he doesn't look in any condition to fix anything. Show More Summary
UT Southwestern Medical Center cancer researchers are investigating whether an injectable, biodegradable gel can reduce potential side effects from extreme high-dose radiation treatments for prostate cancer.
A newly published review article out of University Hospitals Case Medical Center's Seidman Cancer Center in Cleveland provides important guidance about the prostate specific antigen (PSA) test. The peer-reviewed article, titled Prostate Cancer Screening and the Associated Controversy, was published in the October issue of Surgical Clinics of North America.
Over 233,000 men will be diagnosed with prostate cancer this year. Most men along with their families are faced with a vast amount of treatment options. With a quick Google search, one can dive deep into any one treatment and a number of comparisons from various experts. Show More Summary
Rutgers Cancer Institute of New Jersey researcher Justin Drake PhD, has been awarded $450,000 in grants to support a pair of three-year projects aimed at developing biomarkers to predict disease progression and guide treatment strategies for advanced prostate cancer using a combination of laboratory cancer models, computational and targeted mass spectrometry approaches.
Reboots are in, and Rod Stewart knows it. He and Faces band mates Ronnie Wood and Kenney Jones reunited on Saturday in Surrey to play a one-off benefit concert for Prostate Cancer UK—Jones, who had prostate cancer in 2013, instigated the reunion. Show More Summary
Researchers have discovered new drug-like compounds that could ultimately be developed into medicines that offer better odds of survival to prostate cancer patients. The new compounds target the human protein P-gp, which causes resistance against a majority of the drugs currently available for treating cancer and HIV/AIDS. Show More Summary
My patient mix comes in waves — some months it is mostly women with breast cancer struggling with adjuvant endocrine therapy or men in the aftermath of surgery for prostate cancer. These past two months, it has been young adults, and my heart has taken a beating. There is something quite different from my perspective […]
Photo via Twitter Last night, as promised, the Faces reunited for a benefit concert supporting Prostate Cancer UK. Rod Stewart, Ronnie Wood, and Kenney Jones played through a short set of their hits at Hurtwood Park Polo Club in Ewhurst, Surrey. Show More Summary